MedKoo Cat#: 125825 | Name: KCL-286

Description:

WARNING: This product is for research use only, not for human or veterinary use.

KCL-286 is an oral RARβ agonist.

Chemical Structure

KCL-286
KCL-286
CAS#1952276-71-9

Theoretical Analysis

MedKoo Cat#: 125825

Name: KCL-286

CAS#: 1952276-71-9

Chemical Formula: C19H14N2O4

Exact Mass: 334.1000

Molecular Weight: 334.33

Elemental Analysis: C, 68.26; H, 4.22; N, 8.38; O, 19.14

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BHBA001; BHBA-001; UNII-N8LRS5GBB6; N8LRS5GBB6; C286; KCL-286; C-286; Rarbeta agonist compound 10
IUPAC/Chemical Name
4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid
InChi Key
AVCXUODHLRZJJP-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H14N2O4/c1-10-3-4-11(2)16-14(10)9-15(24-16)18-20-17(21-25-18)12-5-7-13(8-6-12)19(22)23/h3-9H,1-2H3,(H,22,23)
SMILES Code
CC1=C2C=C(C3=NC(C4=CC=C(C(O)=O)C=C4)=NO3)OC2=C(C)C=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 334.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Goncalves MB, Mant T, Täubel J, Clarke E, Hassanin H, Bendel D, Fok H, Posner J, Holmes J, Mander AP, Corcoran JPT. Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants. Br J Clin Pharmacol. 2023 Dec;89(12):3573-3583. doi: 10.1111/bcp.15854. Epub 2023 Aug 9. PMID: 37452623.